In this study, we show that cancer cells of neuroepithelial origin, namely melanoma and glioblastoma, can abundantly produce bHB when treated with fenofibrate, a potent PPARa pharmacological agonist and a hypolipidemic drug. This evidence concerns the gene PPARA and glioblastoma.